Life Sciences Pitch Event

Wharton Alumni Angels has invited the below Life Sciences companies to pitch to WAA Members and Guests on Wednesday, 30-Jan-2025 from 4pm - 6:00pm PT // 7pm - 9:00pm ET.  This event will be recorded and posted.

Each company will be allotted a total of 20 minutes for their pitch presentation and Q&A.

This event is open to both Wharton Alumni Angels Members and non-Members - - Feel free to forward to interested parties.

Attendees are invited and encouraged to participate in the post pitch discussion following the last presentation.

Registration is not required for this event.

Selected Life Sciences companies presenting during this meeting will be announced on this event page as event date approaches (and, for WAA Members, on Dealum* (Funnel => Pitch Day")).

Joining Information:

Wharton Alumni Angels is inviting you to a scheduled Zoom meeting.

Topic: Life Sciences Pitch Event

Time: Jan 30, 2025 07:00 PM Eastern Time (US and Canada)

Join Zoom Meeting https://us06web.zoom.us/j/4039237871?pwd=VUZNd2haNVZ6SXRqRkU0YTY2MXlHdz09&omn=87286853470

Meeting ID: 403 923 7871

Passcode: DnRy76

  CPR Therapeutics is developing a revolutionary resuscitation device for in-hospital and EMS to treat cardiac arrest.

⭐ Sourced by James Carroll

PROBLEM: Sudden cardiac arrest is the primary cause of death in developed nations. Our device improves survival without causing the common CPR complication of breaking the rib cage. The significant reduction in mortality and morbidity makes a safe and effective CPR device a crucial unmet medical need.

SOLUTION: The CPR-T system provides multimodal CPR that combines thoracic, cardiac and abdominal pumps to improve efficacy over the pump mechanism of manual CPR and all previous devices. The CPR-T System also integrates electrophysiologic therapies and diagnostics. This will re-start hearts at a much higher rate while protecting the brain from injury.

DEALUM (view company profile, and when available in "DOCUMENTS" tab, pitch deck, deal terms, submit due diligence questions, etc.)

#1-cpr-therapeutics on SLACK

  HEARTio applies its patented AI software to identify obstructive coronary artery disease (CAD) with any input ECG.

⭐ Sourced by Ramesh Gupta

PROBLEM: HEARTio tackles the issue of inaccurate cardiovascular diagnosis. Annually, many Americans face unnecessary procedures or missed critical treatment due to current diagnostic limitations. ECGio, our AI solution, offers rapid, precise cardiac diagnosis, enhancing patient care.

SOLUTION: HEARTio's solution, ECGio, is an AI software that analyzes ECGs to identify heart-related issues more accurately and rapidly. It integrates with hospital systems to detect high-risk patients, providing diagnostic reports within a minute. This aids in quicker and more accurate patient treatment decisions, reducing unnecessary procedures and costs.

DEALUM  (view company profile, and when available in "DOCUMENTS" tab, pitch deck, deal terms, submit due diligence questions, etc.)

#1-heartio on SLACK

  Jeevan Therapeutics is a Boston area biotech start-up, developing novel, next generation therapeutics for colon disease.

⭐ Sourced by James Carroll

PROBLEM: Jeevan is developing therapeutics for >80% of the APC mutated CRC patients lacking beneficial treatment, a leading cause of cancer death in men <50 and 2nd in women; and to rejuvenate aging immune cells that enhance overall cancer treatment efficacy. Our ADC can combine with current therapies providing options for prolonged remission in IBD.

SOLUTION: Jeevan's oral small-molecule targets the Wnt/β-catenin pathway (a communication system inside cells controlling growth), offering a biomarker-driven precision oncology approach with potential coverage for ~80% of CRC patients. Our JTx-ADC is a first-in-class therapy aimed at providing prolonged remission for autoimmune disorders, particularly IBD.

DEALUM  (view company profile, and when available in "DOCUMENTS" tab, pitch deck, deal terms, submit due diligence questions, etc.)

#1-jeevantx on SLACK

  Orchid Surgical is developing the toolkit to unlock surgical video with its head mounted camera and cloud-based platform

⭐ Sourced by James Carroll

PROBLEM: When surgeons complete their training they rarely see another surgeon of their specialty operate again. This is because it is hard to capture what one does in the OR, let alone share it in a HIPAA compliant way.

SOLUTION: We unlock surgical video for surgeons by offering a turn-key solution to integrate filming, storing, editing, and sharing into every surgeon's practice. We do this with easy to use, comfortable hardware, and an intuitive HIPAA compliant cloud platform.

DEALUM  (view company profile, and when available in "DOCUMENTS" tab, pitch deck, deal terms, submit due diligence questions, etc.)

#1-orchid-surgical on SLACK

----------

Wharton Alumni Angels is not a venture fund, an investment bank, a broker/dealer, investment clearing‐house, or an investment advisor. Wharton Alumni Angels is not registered with the U.S. Securities Exchange Commission or any other state’s or nation’s securities commission. For tax, compliance, reporting, legal or other requirements, it is highly recommended that members seek appropriate professional help. No representation or warranty is made as to the accuracy or completeness of the information provided by Wharton Alumni Angels or companies presenting investment opportunities. Wharton Alumni Angels presumes that any offering conducted by companies is a private placement and does not involve a public solicitation of investment.